25 XP   0   0   10

Neuronetics Inc
Buy, Hold or Sell?

Let's analyse Neuronetics Inc together

PenkeI guess you are interested in Neuronetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Neuronetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Neuronetics Inc

I send you an email if I find something interesting about Neuronetics Inc.

Quick analysis of Neuronetics Inc (30 sec.)










What can you expect buying and holding a share of Neuronetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.15
Expected worth in 1 year
$0.38
How sure are you?
10.3%

+ What do you gain per year?

Total Gains per Share
$-0.77
Return On Investment
-19.9%

For what price can you sell your share?

Current Price per Share
$3.86
Expected price per share
$3.44 - $5.0699
How sure are you?
50%

1. Valuation of Neuronetics Inc (5 min.)




Live pricePrice per Share (EOD)

$3.86

Intrinsic Value Per Share

$-3.51 - $-3.75

Total Value Per Share

$-2.37 - $-2.60

2. Growth of Neuronetics Inc (5 min.)




Is Neuronetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$34.1m$66.2m-$24.7m-59.7%

How much money is Neuronetics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.7m-$9.8m$2.1m27.3%
Net Profit Margin-44.6%-61.2%--

How much money comes from the company's main activities?

3. Financial Health of Neuronetics Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#91 / 145

Most Revenue
#89 / 145

Most Profit
#102 / 145

What can you expect buying and holding a share of Neuronetics Inc? (5 min.)

Welcome investor! Neuronetics Inc's management wants to use your money to grow the business. In return you get a share of Neuronetics Inc.

What can you expect buying and holding a share of Neuronetics Inc?

First you should know what it really means to hold a share of Neuronetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Neuronetics Inc is $3.86. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neuronetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neuronetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.15. Based on the TTM, the Book Value Change Per Share is $-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neuronetics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-4.7%-0.25-6.6%-0.31-8.1%-0.26-6.7%-0.24-6.2%
Usd Book Value Change Per Share-0.13-3.3%-0.19-5.0%-0.24-6.1%-0.06-1.6%0.041.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.13-3.3%-0.19-5.0%-0.24-6.1%-0.06-1.6%0.041.0%
Usd Price Per Share2.90-2.33-4.07-6.27-7.01-
Price to Earnings Ratio-4.01--2.60--3.41--6.98--8.19-
Price-to-Total Gains Ratio-23.01--15.14--18.52--37.49--37.35-
Price to Book Ratio2.52-1.70-1.91-3.44-2.95-
Price-to-Total Gains Ratio-23.01--15.14--18.52--37.49--37.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.86
Number of shares259
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.19-0.06
Usd Total Gains Per Share-0.19-0.06
Gains per Quarter (259 shares)-49.77-16.04
Gains per Year (259 shares)-199.06-64.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-199-2090-64-74
20-398-4080-128-138
30-597-6070-192-202
40-796-8060-257-266
50-995-10050-321-330
60-1194-12040-385-394
70-1393-14030-449-458
80-1593-16020-513-522
90-1792-18010-577-586
100-1991-20000-642-650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.028.00.03.4%1.028.00.03.4%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%3.023.03.010.3%3.023.03.010.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%3.023.03.010.3%3.023.03.010.3%

Fundamentals of Neuronetics Inc

About Neuronetics Inc

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-12 19:15:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Neuronetics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neuronetics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -26.5% means that $-0.26 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neuronetics Inc:

  • The MRQ is -26.5%. The company is making a huge loss. -2
  • The TTM is -44.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-26.5%TTM-44.6%+18.1%
TTM-44.6%YOY-61.2%+16.6%
TTM-44.6%5Y-54.0%+9.3%
5Y-54.0%10Y-53.2%-0.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.5%-7.7%-18.8%
TTM-44.6%-6.7%-37.9%
YOY-61.2%2.4%-63.6%
5Y-54.0%-1.5%-52.5%
10Y-53.2%-3.4%-49.8%
1.1.2. Return on Assets

Shows how efficient Neuronetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • -4.6% Return on Assets means that Neuronetics Inc generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neuronetics Inc:

  • The MRQ is -4.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-7.6%+3.0%
TTM-7.6%YOY-8.0%+0.4%
TTM-7.6%5Y-7.2%-0.4%
5Y-7.2%10Y-10.3%+3.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.6%-1.7%-2.9%
TTM-7.6%-1.3%-6.3%
YOY-8.0%-0.9%-7.1%
5Y-7.2%-0.5%-6.7%
10Y-10.3%-0.9%-9.4%
1.1.3. Return on Equity

Shows how efficient Neuronetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • -15.7% Return on Equity means Neuronetics Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neuronetics Inc:

  • The MRQ is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.7%TTM-18.6%+2.8%
TTM-18.6%YOY-14.8%-3.8%
TTM-18.6%5Y-15.3%-3.3%
5Y-15.3%10Y-11.1%-4.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.7%-0.7%-15.0%
TTM-18.6%-0.1%-18.5%
YOY-14.8%0.3%-15.1%
5Y-15.3%-1.4%-13.9%
10Y-11.1%-2.3%-8.8%

1.2. Operating Efficiency of Neuronetics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neuronetics Inc is operating .

  • Measures how much profit Neuronetics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -21.8% means the company generated $-0.22  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neuronetics Inc:

  • The MRQ is -21.8%. The company is operating very inefficient. -2
  • The TTM is -38.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-21.8%TTM-38.2%+16.4%
TTM-38.2%YOY-54.8%+16.6%
TTM-38.2%5Y-46.7%+8.5%
5Y-46.7%10Y-45.7%-1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.8%-6.2%-15.6%
TTM-38.2%0.5%-38.7%
YOY-54.8%4.3%-59.1%
5Y-46.7%3.7%-50.4%
10Y-45.7%-1.3%-44.4%
1.2.2. Operating Ratio

Measures how efficient Neuronetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are $1.22 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Neuronetics Inc:

  • The MRQ is 1.218. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.442. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.218TTM1.442-0.224
TTM1.442YOY1.548-0.106
TTM1.4425Y1.484-0.042
5Y1.48410Y1.561-0.077
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2181.296-0.078
TTM1.4421.301+0.141
YOY1.5481.238+0.310
5Y1.4841.268+0.216
10Y1.5611.217+0.344

1.3. Liquidity of Neuronetics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neuronetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.73 means the company has $4.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Neuronetics Inc:

  • The MRQ is 4.734. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.974. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.734TTM4.974-0.240
TTM4.974YOY4.960+0.014
TTM4.9745Y5.519-0.546
5Y5.51910Y4.687+0.832
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7342.111+2.623
TTM4.9742.298+2.676
YOY4.9602.581+2.379
5Y5.5193.012+2.507
10Y4.6873.081+1.606
1.3.2. Quick Ratio

Measures if Neuronetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 4.00 means the company can pay off $4.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neuronetics Inc:

  • The MRQ is 4.004. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.082. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.004TTM4.082-0.078
TTM4.082YOY4.462-0.381
TTM4.0825Y5.054-0.973
5Y5.05410Y4.251+0.803
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0041.204+2.800
TTM4.0821.285+2.797
YOY4.4621.565+2.897
5Y5.0541.925+3.129
10Y4.2512.128+2.123

1.4. Solvency of Neuronetics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neuronetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neuronetics Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.70 means that Neuronetics Inc assets are financed with 70.5% credit (debt) and the remaining percentage (100% - 70.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neuronetics Inc:

  • The MRQ is 0.705. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.594. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.705TTM0.594+0.111
TTM0.594YOY0.459+0.135
TTM0.5945Y0.504+0.090
5Y0.50410Y1.073-0.569
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7050.421+0.284
TTM0.5940.407+0.187
YOY0.4590.394+0.065
5Y0.5040.448+0.056
10Y1.0730.446+0.627
1.4.2. Debt to Equity Ratio

Measures if Neuronetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 238.8% means that company has $2.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neuronetics Inc:

  • The MRQ is 2.388. The company is just not able to pay all its debts with equity.
  • The TTM is 1.547. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.388TTM1.547+0.841
TTM1.547YOY0.859+0.689
TTM1.5475Y1.127+0.420
5Y1.12710Y0.819+0.308
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3880.606+1.782
TTM1.5470.567+0.980
YOY0.8590.631+0.228
5Y1.1270.658+0.469
10Y0.8190.742+0.077

2. Market Valuation of Neuronetics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neuronetics Inc generates.

  • Above 15 is considered overpriced but always compare Neuronetics Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -4.01 means the investor is paying $-4.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neuronetics Inc:

  • The EOD is -5.340. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.012. Based on the earnings, the company is expensive. -2
  • The TTM is -2.601. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.340MRQ-4.012-1.328
MRQ-4.012TTM-2.601-1.411
TTM-2.601YOY-3.411+0.811
TTM-2.6015Y-6.982+4.382
5Y-6.98210Y-8.192+1.209
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-5.340-0.261-5.079
MRQ-4.012-0.409-3.603
TTM-2.601-0.341-2.260
YOY-3.4110.002-3.413
5Y-6.9824.832-11.814
10Y-8.1925.198-13.390
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Neuronetics Inc:

  • The EOD is 22.898. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.203. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 3.227. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD22.898MRQ17.203+5.695
MRQ17.203TTM3.227+13.977
TTM3.227YOY-5.391+8.617
TTM3.2275Y-7.223+10.450
5Y-7.22310Y-9.775+2.552
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD22.898-0.291+23.189
MRQ17.203-0.441+17.644
TTM3.227-1.388+4.615
YOY-5.391-2.079-3.312
5Y-7.223-1.446-5.777
10Y-9.775-1.971-7.804
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neuronetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.52 means the investor is paying $2.52 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Neuronetics Inc:

  • The EOD is 3.359. Based on the equity, the company is fair priced.
  • The MRQ is 2.524. Based on the equity, the company is underpriced. +1
  • The TTM is 1.695. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.359MRQ2.524+0.836
MRQ2.524TTM1.695+0.829
TTM1.695YOY1.914-0.219
TTM1.6955Y3.444-1.749
5Y3.44410Y2.952+0.491
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.3591.857+1.502
MRQ2.5242.228+0.296
TTM1.6952.222-0.527
YOY1.9143.104-1.190
5Y3.4443.447-0.003
10Y2.9524.036-1.084
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Neuronetics Inc.

3.1. Institutions holding Neuronetics Inc

Institutions are holding 60.587% of the shares of Neuronetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Cannell Capital LLC9.30661.74132769268-64714-2.2835
2023-12-31Archon Capital Management LLC8.52631.81942537097-340609-11.8361
2023-12-31Balyasny Asset Management LLC4.76450.00771417722212391.5209
2023-12-31Vanguard Group Inc4.54750.0001135314400
2023-12-31Silvercrest Asset Management Group LLC3.78570.0231112648400
2023-12-31Kent Lake Capital LLC3.75061.24991116041-1213246-52.0866
2023-12-31Arnhold & S. Bleichroeder Advisers, LLC2.60790.005477600900
2023-12-31Millrace Asset Group, Inc2.43772.0825725369487591205.0614
2023-12-31First Washington Corp1.58180.5249470683-40513-7.9251
2023-12-31BlackRock Inc1.27750380129-786-0.2063
2023-12-31Dafna Capital Management LLC1.05430.21831371700
2023-12-31Acadian Asset Management LLC1.00320.0034298519-70985-19.2109
2023-12-31Geode Capital Management, LLC0.89260.0001265604158656.3526
2023-09-30TANG CAPITAL MANAGEMENT LLC0.67210.038120000000
2023-09-30Citadel Advisors Llc0.64720.0001192576-48507-20.1205
2023-12-31Thompson, Siegel & Walmsley LLC0.63150.00881879131879130
2023-12-31HighTower Advisors, LLC0.61560.00091831662600016.543
2023-12-31Renaissance Technologies Corp0.5680.0008169000-159475-48.5501
2023-12-31Marshall Wace Asset Management Ltd0.48170.00071433281433280
2023-12-31Dimensional Fund Advisors, Inc.0.38530.00011146524023954.0752
Total 49.53767.725314740421-1016660-6.9%

3.2. Funds holding Neuronetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.85490.0002849497-53229-5.8965
2024-02-29First Eagle Small Cap Opportunity I2.41820.121971956300
2023-12-31First Eagle US Small Cap Strategy2.41820.123671956300
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.35730.001240387800
2023-12-31Silvercrest U.S. Small Cap Growth1.23720.541936814100
2023-12-31LoCorr Dynamic Opportunity I0.53811.099916011596895153.2664
2024-02-29Fidelity Extended Market Index0.51590.0012153521-744-0.4823
2023-09-30BlackRock Extended Mkt Composite0.20770.00066179500
2023-12-31Bridgeway Ultra-Small Company Market0.20230.09460205-25000-29.341
2024-03-28iShares Micro-Cap ETF0.20110.0315985418963.2713
2024-03-31BlackRock Extended Equity Market K0.18120.001853930190.0352
2024-02-29Fidelity Total Market Index0.13580.00014042200
2024-02-29DFA US Core Equity 2 I0.13520.00044023900
2024-02-29Fidelity Series Total Market Index0.12980.000238614-2054-5.0507
2024-02-29Fidelity OTC0.12940.00043851000
2024-02-291290 VT GAMCO Small Company Value IB0.11760.00293500000
2023-12-31Northern Trust Extended Eq Market Idx0.08190.00122436000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08190.00122436000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0750.0012231000
2023-12-31Gabelli Small Cap Growth AAA0.06720.00342000000
Total 13.08592.02813893877+17783+0.5%

3.3. Insider Transactions

Insiders are holding 6.875% of the shares of Neuronetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-28William Andrew MacanSELL223773.16
2024-02-27Stephen FurlongSELL212723.33
2024-02-26Keith J SullivanSELL202923.3
2024-02-22Keith J SullivanSELL208513.23
2024-02-20Keith J SullivanSELL239582.96
2024-02-14William Andrew MacanSELL156213.38
2024-02-09Stephen FurlongSELL147103.51
2024-02-06William Andrew MacanSELL53853.39
2024-02-06Stephen FurlongSELL58133.39
2024-01-10Keith J SullivanSELL100133.01
2023-12-21William Andrew MacanSELL116632.52
2023-12-19William Andrew MacanSELL116642.24
2023-10-06Stephen FurlongSELL14991.16
2023-10-06William Andrew MacanSELL14691.16
2023-07-21Keith J SullivanSELL65512.04
2023-07-19Keith J SullivanSELL64792.07
2023-07-11William Andrew MacanSELL26452.13

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Neuronetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.126-0.192+52%-0.236+87%-0.062-51%0.040-418%
Book Value Per Share--1.1491.394-18%2.227-48%1.937-41%1.011+14%
Current Ratio--4.7344.974-5%4.960-5%5.519-14%4.687+1%
Debt To Asset Ratio--0.7050.594+19%0.459+53%0.504+40%1.073-34%
Debt To Equity Ratio--2.3881.547+54%0.859+178%1.127+112%0.819+192%
Dividend Per Share----0%-0%-0%-0%
Eps---0.181-0.254+40%-0.312+73%-0.261+44%-0.239+32%
Free Cash Flow Per Share--0.042-0.289+786%-0.286+778%-0.267+735%-0.233+654%
Free Cash Flow To Equity Per Share--0.790-0.098+112%-0.282+136%-0.081+110%0.041+1829%
Gross Profit Margin--3.1792.725+17%2.298+38%2.431+31%2.456+29%
Intrinsic Value_10Y_max---3.749--------
Intrinsic Value_10Y_min---3.515--------
Intrinsic Value_1Y_max---1.002--------
Intrinsic Value_1Y_min---0.984--------
Intrinsic Value_3Y_max---2.533--------
Intrinsic Value_3Y_min---2.428--------
Intrinsic Value_5Y_max---3.489--------
Intrinsic Value_5Y_min---3.279--------
Market Cap114858546.000+25%86292690.00069257322.750+25%121181717.250-29%186511234.800-54%208682607.517-59%
Net Profit Margin---0.265-0.446+69%-0.612+131%-0.540+104%-0.532+101%
Operating Margin---0.218-0.382+75%-0.548+151%-0.467+114%-0.457+109%
Operating Ratio--1.2181.442-16%1.548-21%1.484-18%1.561-22%
Pb Ratio3.359+25%2.5241.695+49%1.914+32%3.444-27%2.952-15%
Pe Ratio-5.340-33%-4.012-2.601-35%-3.411-15%-6.982+74%-8.192+104%
Price Per Share3.860+25%2.9002.328+25%4.073-29%6.268-54%7.013-59%
Price To Free Cash Flow Ratio22.898+25%17.2033.227+433%-5.391+131%-7.223+142%-9.775+157%
Price To Total Gains Ratio-30.621-33%-23.005-15.145-34%-18.521-19%-37.489+63%-37.347+62%
Quick Ratio--4.0044.082-2%4.462-10%5.054-21%4.251-6%
Return On Assets---0.046-0.076+64%-0.080+72%-0.072+55%-0.103+123%
Return On Equity---0.157-0.186+18%-0.148-6%-0.153-3%-0.111-30%
Total Gains Per Share---0.126-0.192+52%-0.236+87%-0.062-51%0.040-418%
Usd Book Value--34190000.00041488250.000-18%66267750.000-48%57637800.000-41%30090275.862+14%
Usd Book Value Change Per Share---0.126-0.192+52%-0.236+87%-0.062-51%0.040-418%
Usd Book Value Per Share--1.1491.394-18%2.227-48%1.937-41%1.011+14%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.181-0.254+40%-0.312+73%-0.261+44%-0.239+32%
Usd Free Cash Flow--1254000.000-8601750.000+786%-8502000.000+778%-7958300.000+735%-6943827.586+654%
Usd Free Cash Flow Per Share--0.042-0.289+786%-0.286+778%-0.267+735%-0.233+654%
Usd Free Cash Flow To Equity Per Share--0.790-0.098+112%-0.282+136%-0.081+110%0.041+1829%
Usd Market Cap114858546.000+25%86292690.00069257322.750+25%121181717.250-29%186511234.800-54%208682607.517-59%
Usd Price Per Share3.860+25%2.9002.328+25%4.073-29%6.268-54%7.013-59%
Usd Profit---5377000.000-7700500.000+43%-9801000.000+82%-7884750.000+47%-7209827.586+34%
Usd Revenue--20314000.00017837000.000+14%16301500.000+25%15188300.000+34%14027241.379+45%
Usd Total Gains Per Share---0.126-0.192+52%-0.236+87%-0.062-51%0.040-418%
 EOD+4 -4MRQTTM+23 -11YOY+20 -145Y+17 -1710Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of Neuronetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.340
Price to Book Ratio (EOD)Between0-13.359
Net Profit Margin (MRQ)Greater than0-0.265
Operating Margin (MRQ)Greater than0-0.218
Quick Ratio (MRQ)Greater than14.004
Current Ratio (MRQ)Greater than14.734
Debt to Asset Ratio (MRQ)Less than10.705
Debt to Equity Ratio (MRQ)Less than12.388
Return on Equity (MRQ)Greater than0.15-0.157
Return on Assets (MRQ)Greater than0.05-0.046
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Neuronetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.315
Ma 20Greater thanMa 504.250
Ma 50Greater thanMa 1003.888
Ma 100Greater thanMa 2003.340
OpenGreater thanClose4.130
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets115,831
Total Liabilities81,641
Total Stockholder Equity34,190
 As reported
Total Liabilities 81,641
Total Stockholder Equity+ 34,190
Total Assets = 115,831

Assets

Total Assets115,831
Total Current Assets93,793
Long-term Assets22,038
Total Current Assets
Cash And Cash Equivalents 59,677
Short-term Investments 905
Net Receivables 17,838
Inventory 8,093
Other Current Assets 7,280
Total Current Assets  (as reported)93,793
Total Current Assets  (calculated)93,793
+/-0
Long-term Assets
Property Plant Equipment 4,782
Long Term Investments 661
Long-term Assets Other 12,800
Long-term Assets  (as reported)22,038
Long-term Assets  (calculated)18,243
+/- 3,795

Liabilities & Shareholders' Equity

Total Current Liabilities19,812
Long-term Liabilities61,829
Total Stockholder Equity34,190
Total Current Liabilities
Short-term Debt 845
Accounts payable 4,752
Other Current Liabilities 12,595
Total Current Liabilities  (as reported)19,812
Total Current Liabilities  (calculated)18,192
+/- 1,620
Long-term Liabilities
Long term Debt 59,283
Capital Lease Obligations Min Short Term Debt2,346
Long-term Liabilities  (as reported)61,829
Long-term Liabilities  (calculated)61,629
+/- 200
Total Stockholder Equity
Common Stock291
Retained Earnings -376,081
Other Stockholders Equity 409,980
Total Stockholder Equity (as reported)34,190
Total Stockholder Equity (calculated)34,190
+/-0
Other
Capital Stock291
Cash and Short Term Investments 60,582
Common Stock Shares Outstanding 29,048
Current Deferred Revenue1,620
Liabilities and Stockholders Equity 115,831
Net Debt 2,797
Net Invested Capital 93,473
Net Working Capital 73,981
Property Plant and Equipment Gross 7,604
Short Long Term Debt Total 62,474



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
24,798
0
0
0
38,938
32,016
28,345
118,979
117,022
113,437
109,426
105,481
100,168
88,455
79,994
78,339
78,657
152,307
148,098
143,068
141,223
129,944
122,953
119,235
116,884
103,604
100,392
92,988
115,831
115,83192,988100,392103,604116,884119,235122,953129,944141,223143,068148,098152,30778,65778,33979,99488,455100,168105,481109,426113,437117,022118,97928,34532,01638,93800024,798
   > Total Current Assets 
22,920
0
0
0
37,005
29,775
26,001
116,739
114,473
106,043
101,297
95,906
88,451
76,432
67,212
65,200
65,012
138,946
134,878
119,447
115,331
103,114
95,084
101,096
98,769
81,107
77,676
71,011
93,793
93,79371,01177,67681,10798,769101,09695,084103,114115,331119,447134,878138,94665,01265,20067,21276,43288,45195,906101,297106,043114,473116,73926,00129,77537,00500022,920
       Cash And Cash Equivalents 
17,040
0
0
0
29,147
20,354
14,544
106,760
104,583
96,146
89,644
82,370
75,708
63,647
53,997
50,719
48,957
121,277
115,783
99,434
94,141
80,837
70,931
73,698
70,340
55,443
45,905
35,847
59,677
59,67735,84745,90555,44370,34073,69870,93180,83794,14199,434115,783121,27748,95750,71953,99763,64775,70882,37089,64496,146104,583106,76014,54420,35429,14700017,040
       Short-term Investments 
0
0
0
0
0
0
0
0
0
135
240
633
880
1,117
1,305
1,626
1,887
1,930
2,034
2,142
2,198
2,136
2,096
1,874
1,538
1,257
1,072
968
905
9059681,0721,2571,5381,8742,0962,1362,1982,1422,0341,9301,8871,6261,3051,117880633240135000000000
       Net Receivables 
3,577
0
0
0
4,267
4,282
4,724
5,283
5,620
5,666
7,563
7,552
6,569
6,251
6,636
5,564
7,166
6,964
9,002
7,749
7,780
8,341
11,486
12,043
13,821
10,950
15,120
16,874
17,838
17,83816,87415,12010,95013,82112,04311,4868,3417,7807,7499,0026,9647,1665,5646,6366,2516,5697,5527,5635,6665,6205,2834,7244,2824,2670003,577
       Inventory 
1,696
0
0
0
2,468
2,597
2,441
2,614
2,432
2,410
2,552
2,924
2,775
2,879
3,332
3,779
3,720
5,401
5,393
5,355
6,563
7,551
7,185
8,573
8,899
9,142
8,871
9,737
8,093
8,0939,7378,8719,1428,8998,5737,1857,5516,5635,3555,3935,4013,7203,7793,3322,8792,7752,9242,5522,4102,4322,6142,4412,5972,4680001,696
       Other Current Assets 
607
0
0
0
1,123
2,542
4,292
2,082
1,838
1,627
1,061
1,985
1,830
1,799
1,091
2,662
2,186
2,239
1,447
3,454
3,090
4,249
3,386
4,908
2,174
2,218
4,504
5,234
7,280
7,2805,2344,5042,2182,1744,9083,3864,2493,0903,4541,4472,2392,1862,6621,0911,7991,8301,9851,0611,6271,8382,0824,2922,5421,123000607
   > Long-term Assets 
0
0
0
0
1,933
2,241
2,344
2,240
2,549
7,394
8,129
9,575
11,717
12,022
12,782
13,139
13,645
13,361
13,220
23,621
25,892
26,830
27,869
18,139
18,115
22,497
22,716
21,977
22,038
22,03821,97722,71622,49718,11518,13927,86926,83025,89223,62113,22013,36113,64513,13912,78212,02211,7179,5758,1297,3942,5492,2402,3442,2411,9330000
       Property Plant Equipment 
1,628
0
0
0
1,359
1,440
1,493
1,343
1,378
5,323
5,103
4,886
4,903
4,666
4,438
4,302
4,148
4,186
3,936
4,051
5,104
5,572
5,681
5,568
5,318
5,183
5,164
4,982
4,782
4,7824,9825,1645,1835,3185,5685,6815,5725,1044,0513,9364,1864,1484,3024,4384,6664,9034,8865,1035,3231,3781,3431,4931,4401,3590001,628
       Long Term Investments 
0
0
0
0
0
0
0
0
0
225
400
1,141
1,730
1,861
2,082
2,255
2,331
1,958
1,854
10,000
1,697
1,369
10,089
1,617
362
989
4,671
700
661
6617004,6719893621,61710,0891,3691,69710,0001,8541,9582,3312,2552,0821,8611,7301,141400225000000000
       Intangible Assets 
0
0
0
0
400
0
0
700
1,000
1,200
1,100
900
1,200
0
0
0
0
0
0
0
0
0
0
0
3,600
0
0
0
0
00003,600000000000001,2009001,1001,2001,000700004000000
       Long-term Assets Other 
0
0
0
0
574
801
851
897
1,171
1,846
2,626
3,548
5,084
5,495
6,262
6,582
7,166
7,217
7,430
17,835
19,091
19,889
20,506
10,954
11,575
16,325
16,693
16,295
12,800
12,80016,29516,69316,32511,57510,95420,50619,88919,09117,8357,4307,2177,1666,5826,2625,4955,0843,5482,6261,8461,1718978518015740000
> Total Liabilities 
29,611
0
0
0
231,590
42,369
233,616
42,631
45,980
48,016
49,607
51,151
52,316
51,944
50,554
50,861
53,164
50,336
50,932
51,992
56,048
53,346
54,531
56,244
59,824
55,259
54,915
55,047
81,641
81,64155,04754,91555,25959,82456,24454,53153,34656,04851,99250,93250,33653,16450,86150,55451,94452,31651,15149,60748,01645,98042,631233,61642,369231,59000029,611
   > Total Current Liabilities 
13,338
0
0
0
11,994
10,253
14,845
15,298
13,559
11,861
16,607
22,002
27,693
12,386
45,348
45,781
13,682
10,907
11,578
47,809
15,703
13,183
18,937
25,143
33,199
15,130
15,026
15,336
19,812
19,81215,33615,02615,13033,19925,14318,93713,18315,70347,80911,57810,90713,68245,78145,34812,38627,69322,00216,60711,86113,55915,29814,84510,25311,99400013,338
       Short-term Debt 
4,491
20,138
0
0
29,556
29,803
2,500
5,000
0
515
4,266
8,029
11,809
566
34,950
35,127
594
602
612
35,720
670
729
5,155
9,568
13,949
829
834
840
845
84584083482913,9499,5685,15572967035,72061260259435,12734,95056611,8098,0294,26651505,0002,50029,80329,5560020,1384,491
       Short Long Term Debt 
4,491
20,138
0
0
29,556
29,803
2,500
5,000
0
515
3,750
7,500
11,250
0
34,373
34,542
0
0
0
35,104
0
0
4,375
8,750
13,125
0
0
0
0
000013,1258,7504,3750035,10400034,54234,373011,2507,5003,75051505,0002,50029,80329,5560020,1384,491
       Accounts payable 
1,483
0
0
0
2,513
2,968
2,928
2,102
3,756
2,588
3,659
4,109
4,625
3,610
2,324
2,368
3,749
3,241
2,425
3,306
4,299
2,757
2,350
2,350
2,433
4,970
4,143
2,822
4,752
4,7522,8224,1434,9702,4332,3502,3502,7574,2993,3062,4253,2413,7492,3682,3243,6104,6254,1093,6592,5883,7562,1022,9282,9682,5130001,483
       Other Current Liabilities 
7,364
0
0
0
7,511
5,670
7,731
6,383
7,548
6,291
6,476
7,612
9,031
5,955
5,661
6,171
7,319
5,152
6,604
6,913
8,233
7,785
9,684
11,493
14,837
7,440
8,375
10,037
12,595
12,59510,0378,3757,44014,83711,4939,6847,7858,2336,9136,6045,1527,3196,1715,6615,9559,0317,6126,4766,2917,5486,3837,7315,6707,5110007,364
   > Long-term Liabilities 
0
0
0
0
219,596
32,116
218,771
27,333
32,421
36,155
33,000
29,149
24,623
39,558
5,206
5,080
39,482
39,429
39,354
4,183
40,345
40,163
35,594
31,101
26,625
40,129
39,889
39,711
61,829
61,82939,71139,88940,12926,62531,10135,59440,16340,3454,18339,35439,42939,4825,0805,20639,55824,62329,14933,00036,15532,42127,333218,77132,116219,5960000
       Long term Debt Total 
0
0
0
0
0
0
27,497
25,198
30,395
30,572
27,007
23,450
19,898
34,210
0
0
34,620
34,791
34,944
0
0
0
31,210
27,009
22,829
36,641
36,713
0
0
0036,71336,64122,82927,00931,21000034,94434,79134,6200034,21019,89823,45027,00730,57230,39525,19827,497000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
4,249
4,158
3,999
3,178
3,930
3,848
3,802
3,715
3,626
3,534
3,438
4,209
4,124
4,035
3,929
3,791
3,646
3,497
3,346
3,191
3,1913,3463,4973,6463,7913,9294,0354,1244,2093,4383,5343,6263,7153,8023,8483,9303,1783,9994,1584,249000000000
       Warrants
0
0
0
0
0
0
187,136
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000187,136000000
       Long-term Liabilities Other 
0
0
0
0
0
0
1,893
0
0
3,734
3,642
3,470
2,619
3,364
3,271
3,217
3,121
3,024
2,922
2,822
0
0
3,255
3,111
2,967
2,817
2,663
0
0
002,6632,8172,9673,1113,255002,8222,9223,0243,1213,2173,2713,3642,6193,4703,6423,734001,893000000
       Deferred Long Term Liability 
0
0
0
0
0
0
2,245
2,135
2,026
456
1,342
2,465
3,779
4,148
4,340
1,863
1,741
1,614
5,454
1,361
6,763
6,956
7,163
7,305
829
671
513
0
0
005136718297,3057,1636,9566,7631,3615,4541,6141,7411,8634,3404,1483,7792,4651,3424562,0262,1352,245000000
> Total Stockholder Equity
-177,124
-177,124
0
0
-192,652
-10,353
-205,271
76,348
71,042
65,421
59,819
54,330
47,852
36,511
29,440
27,478
25,493
101,971
97,166
91,076
85,175
76,598
68,422
62,991
57,060
48,345
45,477
37,941
34,190
34,19037,94145,47748,34557,06062,99168,42276,59885,17591,07697,166101,97125,49327,47829,44036,51147,85254,33059,81965,42171,04276,348-205,271-10,353-192,65200-177,124-177,124
   Common Stock
2
0
0
0
2
112
3
176
177
182
184
186
186
187
188
189
191
258
262
263
264
267
268
270
273
285
288
289
291
291289288285273270268267264263262258191189188187186186184182177176311220002
   Retained Earnings -376,081-370,704-361,313-356,412-345,892-337,602-329,993-319,571-308,733-301,097-292,946-285,421-277,540-273,883-270,465-262,700-250,087-242,533-235,666-228,572-221,043-214,900-209,939-202,443-196,946000-180,887
   Capital Surplus 
0
0
0
0
0
0
4,665
291,072
291,908
293,811
295,301
296,677
297,753
299,024
299,717
301,172
302,842
387,134
389,850
391,910
0
0
398,147
400,323
402,679
404,472
406,502
0
0
00406,502404,472402,679400,323398,14700391,910389,850387,134302,842301,172299,717299,024297,753296,677295,301293,811291,908291,0724,665000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
6,123
193,808
4,700
174,068
293,924
295,901
297,448
298,863
299,960
301,264
301,996
301,172
302,842
389,521
392,281
391,910
393,644
395,902
398,147
400,323
402,679
404,472
406,502
408,356
409,980
409,980408,356406,502404,472402,679400,323398,147395,902393,644391,910392,281389,521302,842301,172301,996301,264299,960298,863297,448295,901293,924174,0684,700193,8086,1230000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue71,348
Cost of Revenue-21,649
Gross Profit49,69949,699
 
Operating Income (+$)
Gross Profit49,699
Operating Expense-80,253
Operating Income-30,554-30,554
 
Operating Expense (+$)
Research Development9,515
Selling General Administrative25,426
Selling And Marketing Expenses47,318
Operating Expense80,25382,259
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,424
Other Finance Cost-24
Net Interest Income-5,400
 
Pretax Income (+$)
Operating Income-30,554
Net Interest Income-5,400
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,189-30,919
EBIT - interestExpense = -35,978
-30,189
-24,765
Interest Expense5,424
Earnings Before Interest and Taxes (EBIT)-30,554-24,765
Earnings Before Interest and Taxes (EBITDA)-28,548
 
After tax Income (+$)
Income Before Tax-30,189
Tax Provision-0
Net Income From Continuing Ops-30,165-30,189
Net Income-30,189
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses101,902
Total Other Income/Expenses Net3655,400
 

Technical Analysis of Neuronetics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neuronetics Inc. The general trend of Neuronetics Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neuronetics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Neuronetics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.9 < 4.84 < 5.0699.

The bearish price targets are: 3.7899 > 3.69 > 3.44.

Tweet this
Neuronetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Neuronetics Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Neuronetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Neuronetics Inc. The current macd is -0.05086521.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Neuronetics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Neuronetics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Neuronetics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Neuronetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartNeuronetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Neuronetics Inc. The current adx is 14.66.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Neuronetics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Neuronetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Neuronetics Inc. The current sar is 4.34087491.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Neuronetics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Neuronetics Inc. The current rsi is 43.31. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Neuronetics Inc Daily Relative Strength Index (RSI) ChartNeuronetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Neuronetics Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neuronetics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Neuronetics Inc Daily Stochastic Oscillator ChartNeuronetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Neuronetics Inc. The current cci is -81.7752628.

Neuronetics Inc Daily Commodity Channel Index (CCI) ChartNeuronetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Neuronetics Inc. The current cmo is -24.13782965.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Neuronetics Inc Daily Chande Momentum Oscillator (CMO) ChartNeuronetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Neuronetics Inc. The current willr is -80.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Neuronetics Inc Daily Williams %R ChartNeuronetics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Neuronetics Inc.

Neuronetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Neuronetics Inc. The current atr is 0.31031397.

Neuronetics Inc Daily Average True Range (ATR) ChartNeuronetics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Neuronetics Inc. The current obv is 29,265,418.

Neuronetics Inc Daily On-Balance Volume (OBV) ChartNeuronetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Neuronetics Inc. The current mfi is 32.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Neuronetics Inc Daily Money Flow Index (MFI) ChartNeuronetics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Neuronetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Neuronetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Neuronetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.315
Ma 20Greater thanMa 504.250
Ma 50Greater thanMa 1003.888
Ma 100Greater thanMa 2003.340
OpenGreater thanClose4.130
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neuronetics Inc with someone you think should read this too:
  • Are you bullish or bearish on Neuronetics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neuronetics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Neuronetics Inc

I send you an email if I find something interesting about Neuronetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Neuronetics Inc.

Receive notifications about Neuronetics Inc in your mailbox!